The video provides a fundamental analysis of three stocks: PayPal (PYPL), Bristol-Myers Squibb (BMY), and Target (TGT).For PYPL, the analysis notes a 61% decline over five years, indicating a long base formation, and growing active accounts. Despite revenue growth deceleration, it's accelerating. With $7B in free cash flow and significant share buybacks, the analyst infers a target price of $100. The analysis will be invalidated at $60.BMY trades at seven times earnings with a sustainable dividend yield. Despite impending patent expirations, the video highlights BMY’s strategy of acquiring new drugs to maintain free cash flow. It is assigned a target of $60 and fail price of $40.Target's comp sales have been negative and depend greatly on discretionary expenditures, resulting in a negative outlook. The analysis will be invalidated at a price of $95, with an inferred target of $70.